140 related articles for article (PubMed ID: 38100902)
1. 8-hydroxyquinoline-N-oxide copper(II)- and zinc(II)-phenanthroline and bipyridine coordination compounds: Design, synthesis, structures, and antitumor evaluation.
Du LQ; Zeng CJ; Mo DY; Qin QP; Tan MX; Liang H
J Inorg Biochem; 2024 Feb; 251():112443. PubMed ID: 38100902
[TBL] [Abstract][Full Text] [Related]
2. Ni(ii)/Cu(ii)/Zn(ii) 5,5-diethylbarbiturate complexes with 1,10-phenanthroline and 2,2'-dipyridylamine: synthesis, structures, DNA/BSA binding, nuclease activity, molecular docking, cellular uptake, cytotoxicity and the mode of cell death.
Yilmaz VT; Icsel C; Suyunova F; Aygun M; Aztopal N; Ulukaya E
Dalton Trans; 2016 Jun; 45(25):10466-79. PubMed ID: 27263797
[TBL] [Abstract][Full Text] [Related]
3. Novel glycosylation zinc(II)-cryptolepine complexes perturb mitophagy pathways and trigger cancer cell apoptosis and autophagy in SK-OV-3/DDP cells.
Zhou Z; Du LQ; Huang XM; Zhu LG; Wei QC; Qin QP; Bian H
Eur J Med Chem; 2022 Dec; 243():114743. PubMed ID: 36116236
[TBL] [Abstract][Full Text] [Related]
4. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer mechanisms of zinc(II)-8-hydroxyquinoline complexes with 1,10-phenanthroline ancillary ligands.
Du LQ; Zhang TY; Huang XM; Xu Y; Tan MX; Huang Y; Chen Y; Qin QP
Dalton Trans; 2023 Apr; 52(15):4737-4751. PubMed ID: 36942929
[TBL] [Abstract][Full Text] [Related]
6. Mixed ligand complexes of Cu(II)/Zn(II) ions containing (m-)/(p-) carboxylato phenyl azo pentane 2,4-dione and 2,2'-bipyridine/1,10 phenanthroline: Synthesis, characterization, DNA binding, nuclease and topoisomerase I inhibitory activity.
Hasan MA; Kumari N; Singh K; Singh K; Mishra L
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():208-17. PubMed ID: 26210016
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands.
Anupama B; Aruna A; Manga V; Sivan S; Sagar MV; Chandrashekar R
J Fluoresc; 2017 May; 27(3):953-965. PubMed ID: 28097460
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.
Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR
Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305
[TBL] [Abstract][Full Text] [Related]
9. Reactions of the cationic zinc thiolate model complex [Zn(Tab)4](PF6)2 with N-donor ligands and cobalt dichloride.
Zheng AX; Si J; Tang XY; Miao LL; Yu M; Hou KP; Wang F; Li HX; Lang JP
Inorg Chem; 2012 Oct; 51(19):10262-73. PubMed ID: 22985442
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structures, nuclease activity, cytotoxicity, DFT and molecular docking studies of two nitrato bridged homodinuclear (Cu-Cu, Zn-Zn) complexes containing 2,2'-bipyridine and a chalcone derivative.
Gaur R; Choubey DK; Usman M; Ward BD; Roy JK; Mishra L
J Photochem Photobiol B; 2017 Aug; 173():650-660. PubMed ID: 28711020
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of copper(II) complexes with Schiff bases derived from N'-tosylbenzene-1,2-diamine.
Diz M; Durán-Carril ML; Castro J; Alvo S; Bada L; Viña D; García-Vázquez JA
J Inorg Biochem; 2022 Nov; 236():111975. PubMed ID: 36055108
[TBL] [Abstract][Full Text] [Related]
12. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
Cheng YF; Lu XM; Wang G
Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
[TBL] [Abstract][Full Text] [Related]
13. The π-back-bonding modulation and its impact in the electronic properties of Cu(II) antineoplastic compounds: an experimental and theoretical study.
García-Ramos JC; Galindo-Murillo R; Tovar-Tovar A; Alonso-Saenz AL; Gómez-Vidales V; Flores-Álamo M; Ortiz-Frade L; Cortes-Guzmán F; Moreno-Esparza R; Campero A; Ruiz-Azuara L
Chemistry; 2014 Oct; 20(42):13730-41. PubMed ID: 25196088
[TBL] [Abstract][Full Text] [Related]
14. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
[TBL] [Abstract][Full Text] [Related]
15. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of Cu(II) and Zn(II) 2,2'-bipyridyl complexes: dependence of IC50 on recovery time.
Shi Y; Toms BB; Dixit N; Kumari N; Mishra L; Goodisman J; Dabrowiak JC
Chem Res Toxicol; 2010 Aug; 23(8):1417-26. PubMed ID: 20672868
[TBL] [Abstract][Full Text] [Related]
17. Pyrazolone incorporating bipyridyl metallointercalators as effective DNA, protein and lung cancer targets: Synthesis, characterization and in vitro biocidal evaluation.
Vyas KM; Devkar RV; Prajapati A; Jadeja RN
Chem Biol Interact; 2015 Oct; 240():250-66. PubMed ID: 26341650
[TBL] [Abstract][Full Text] [Related]
18. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
[TBL] [Abstract][Full Text] [Related]
20. Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity.
Jaividhya P; Dhivya R; Akbarsha MA; Palaniandavar M
J Inorg Biochem; 2012 Sep; 114():94-105. PubMed ID: 22841366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
